Aravive, Inc. Stock
Aravive, Inc. Stock
With 0 Sell predictions and 1 Buy predictions the community sentiment towards the Aravive, Inc. stock is not clear.
Based on the current price of 0.03 € the target price of 16 € shows a potential of 49130.77% for Aravive, Inc. which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Aravive, Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Aravive, Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Aravive, Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Aravive, Inc. | - | - | - | - | - | - | - |
Ardelyx Inc. | -0.970% | -1.640% | -11.302% | 48.049% | 3.737% | -18.973% | - |
Salarius Pharmaceuticals Inc. | -1.840% | 1.429% | 0.472% | -70.417% | -23.243% | -98.377% | -99.993% |
Brainstorm Cell | -5.760% | -2.456% | -5.429% | -82.011% | 114.009% | -83.450% | - |
Comments
Aravive, Inc. (NASDAQ: ARAV) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $18.00 price target on the stock.
Show more
Ratings data for ARAV provided by MarketBeat